Skip to main content
OpenTrials

Clinical trial condition

Alopecia Areata

Explore clinical trials studying Alopecia Areata. Study availability and eligibility vary by location and protocol.

144 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Alopecia Areata trial results

Active, Not Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

NCT07023302

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +3 more
Locations
  • Nagoya City University Hospital /ID# 275409 Nagoya, Aichi-ken, Japan
  • Kurume University Hospital /ID# 275519 Kurume-shi, Fukuoka, Japan
  • Kanazawa Medical University Hospital /ID# 275521 Kahoku-gun, Ishikawa-ken, Japan
  • Nagomi Dermatology Clinic /ID# 275418 Ebina-shi, Kanagawa, Japan
View all 15 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT06799520

Conditions
Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
Locations
  • Visterra Investigational Site Sofia, Bulgaria
  • Visterra Investigational Site Chisinau, Moldova
  • Visterra Investigational Site Bucharest, Romania
  • Visterra Investigational Site Cluj-Napoca, Romania
View Trial Details
Active, Not Recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

NCT06340360

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +3 more
Locations
  • Nektar Investigative Site Northridge, California, United States
  • Nektar Investigative Site Atlanta, Georgia, United States
  • Nektar Investigative Site Gurnee, Illinois, United States
  • Nektar Investigative Site Indianapolis, Indiana, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

NCT06602232

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +8 more
Locations
  • Dren Investigational Site Northridge, California, United States
  • Dren Investigational Site Miami, Florida, United States
  • Dren Investigational Site Evans, Georgia, United States
  • Dren Investigational Site Meridian, Idaho, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

NCT07029711

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +4 more
Locations
  • UCI Dermatology Clinical Research Irvine, California, United States
  • Southern California Clinical Research Santa Ana, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

NCT06873945

Conditions
Alopecia, Alopecia Areata, Alopecia universalis, +6 more
Locations
  • The Kirklin Clinic of UAB Hospital (Radiology) Birmingham, Alabama, United States
  • University of Alabama at Birmingham Faculty Office Towers (Regulatory) Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
View all 143 locations
View Trial Details
Active, Not Recruiting

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

NCT06018428

Conditions
Alopecia, Alopecia Areata, Dermatitis, +6 more
Locations
  • Scottsdale, Arizona Scottsdale, Arizona, United States
  • Fayetteville, Arkansas Fayetteville, Arkansas, United States
  • Hot Springs, Arkansas Hot Springs, Arkansas, United States
  • Encinitas, California Encinitas, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details

Related conditions